Ranbaxy gains FDA approval for generic form of GSK's Augmentin |
|
|
|
Published
:
Wed, 31 Jan 2007 17:22
|
LONDON (AFX) - Ranbaxy Laboratories Ltd's unit Ranbaxy Pharmaceuticals said it has been approved by the US FDA to market its Amoxicillin and Clavulanate Potassium drug at the dosage 600 mg/42.9 mg/5 mL in oral suspension, for the treatment of ear infections.The drug was determined to be a therapeutical equivalent of GlaxoSmithKline's Augmentin drug.newsdesk@afxnews.comabrCOPYRIGHTCopyright AFX News Limited 2006. All rights reserved.The copying, republication or redistribution of AFX News Content, including by framing or similar means, is expressly prohibited without the prior written consent of AFX News.AFX News and AFX Financial News Logo are registered trademarks of AFX News Limited
|
|
|
|
|
|
|
| Stock
Quotes * |
|
NASDAQ
|
|
2374.41 |
-16.87 (
-0.71 %)
|
| SYMBOL (
2010-03-19 ) |
| LAST |
CHANGE
|
|
CARNIVAL
(
12:35pm )
|
|
2650.00 |
+52.00 (
2.00 %)
|
|
WHITBREAD
(
12:35pm )
|
|
1540.00 |
+21.00 (
1.37 %)
|
| SYMBOL (
2010-03-19 )
|
| LAST |
CHANGE
|
| SYMBOL (
2010-03-19 )
|
| LAST |
CHANGE
|
|
|
Print this Story
Pfizer to appeal Canadian decision 